Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
CA 2922728 C · Owner: Cedars-Sinai Medical Center · Inventors: Lin, Henry C.; Pimentel, Mark
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome fibromyalgia, chronic pelvic pain syndrome chronic fatigue syndrome, depression, impaired mentation impaired memory, halitosis, tinnitus, sugar craving autism, attention deficit/hyperactivity disorder drug sensitivity, an autoimmune disease and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO- caused condition in a human subject …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 16, 2002 and granted February 12, 2019. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 16, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 16, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.